FragMAX Facility for Crystallographic Fragment and Ligand Screening at MAX IV

Sandesh Kanchugal P., Elmir Jagudin, Gustavo M. A. Lima, Vladimir O. Talibov, Afshan Begum, Jie Nan, Mikel Eguiraun, Ana Gonzalez, Céleste Sele, Maria Nyblom, Wolfgang Knecht, Derek T. Logan, Tove Sjögren, Marjolein Thunnissen, Thomas Ursby, Marc Obiols-Rabasa, Magnus Larsson, Uwe Mueller, Tobias Krojer
{"title":"FragMAX Facility for Crystallographic Fragment and Ligand Screening at MAX IV","authors":"Sandesh Kanchugal P.,&nbsp;Elmir Jagudin,&nbsp;Gustavo M. A. Lima,&nbsp;Vladimir O. Talibov,&nbsp;Afshan Begum,&nbsp;Jie Nan,&nbsp;Mikel Eguiraun,&nbsp;Ana Gonzalez,&nbsp;Céleste Sele,&nbsp;Maria Nyblom,&nbsp;Wolfgang Knecht,&nbsp;Derek T. Logan,&nbsp;Tove Sjögren,&nbsp;Marjolein Thunnissen,&nbsp;Thomas Ursby,&nbsp;Marc Obiols-Rabasa,&nbsp;Magnus Larsson,&nbsp;Uwe Mueller,&nbsp;Tobias Krojer","doi":"10.1002/appl.202400263","DOIUrl":null,"url":null,"abstract":"<p>The FragMAX facility at MAX IV Laboratory is a state-of-the-art platform for crystallographic fragment screening, designed to support structure-based drug and chemical tool compound discovery. This facility offers a comprehensive workflow, from high-throughput crystal preparation and automated diffraction data collection at the BioMAX beamline to advanced data processing and analysis using custom software tools like FragMAXapp and FragMAXproc. Key components include an extensive relational SQLite database, various fragment libraries, laboratory automation equipment, and a range of bespoke software solutions. FragMAX has conducted numerous successful screening campaigns, serving both academic and industrial users. Users benefit from comprehensive support, and stringent data management. Here, we provide an overview of the different components of the facility and details of their practical implementation.</p>","PeriodicalId":100109,"journal":{"name":"Applied Research","volume":"4 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/appl.202400263","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Applied Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/appl.202400263","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

The FragMAX facility at MAX IV Laboratory is a state-of-the-art platform for crystallographic fragment screening, designed to support structure-based drug and chemical tool compound discovery. This facility offers a comprehensive workflow, from high-throughput crystal preparation and automated diffraction data collection at the BioMAX beamline to advanced data processing and analysis using custom software tools like FragMAXapp and FragMAXproc. Key components include an extensive relational SQLite database, various fragment libraries, laboratory automation equipment, and a range of bespoke software solutions. FragMAX has conducted numerous successful screening campaigns, serving both academic and industrial users. Users benefit from comprehensive support, and stringent data management. Here, we provide an overview of the different components of the facility and details of their practical implementation.

求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.70
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信